Global Chondroitin Sulfate Market is valued at approximately USD 1.21 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3.5% over the forecast period 2022-2029. Chondroitin sulfate is also named glycosaminoglycan sulfated glucose (GAG). Chondroitin sulfate is composed of a long chain of alternating sugars such as glucuronic acid and N-acetylga-lactosamine. This molecule is an important part of the extracellular matrix, which is formed of several connective tissues like bone, cartilage, tendons, and ligaments. Commercial production of chondroitin sulfate uses a variety of animal sources, including pigs, chickens, cows, fish, sharks, crocodiles, and other creatures. The rising demand for nutraceutical goods, coupled with the growing demand in animal feed industry are acting as catalyzing factors for the demand for chondroitin sulfate in the global market.
The rising incidencfes of osteoarthritis is playing a ignificant role for propelling the market demand across the globe. The World Health Organization Association (WHO), stated that globally around9.6% of men and 18% of women aged more than 60 are suffering from symptomatic osteoarthritis. Among these, nearly 80% have problems in movement and 25% are not able to perform day-to-day activities. Thereby, the rising incidence rate of orthopedic disorders is likely to stipulate the growth of global plasma therapy market. Thereby, the rising usage of chondroitin sulfate for the treatment of osteoarthritis is augmenting the market expansion at a significant rate. Moreover, rising investment in research and development, as well as the growing applications of chondroitin sulfate are presenting various lucrative opportunities over the forecasting years. However, adverse effects of chondroitin sulfate and stringent regulations by various regulatory bodies are challenging the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Chondroitin Sulfate Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of osteoarthritis, along with the increasing United States Food and Drug Administration approvals for chondroitin sulfate. Whereas, the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as the growing aging population in emerging nations, as well as rising use of sodium chondroitin sulfate-infused pharmaceuticals and nutraceuticals in the market space.
Major market players included in this report are:
TSI Group Ltd.
Qingdao Wan Toulmin Biological Sources Co., Ltd.
Hebei SanXin Industrial Group
Sigma Aldrich, Inc.
Sino Siam Biotechnique Company Ltd.
Bio-gen Extracts Pvt. Ltd.
Recent Developments in the Market:
? In July 2022, Infinitus unveiled the introduction of a new series of Li Mai Jian supplements with the theme ’Making Bones Stronger for Joint Health’.
? In March 2022, Bioiberica, a global life science company announced that the company entered into a partnership agreement with ByHealth, The key objective of this partnership is to introduce a new product for its market-leading joint health brand, Highflex. Highflex type II collagen tablets is developed to fulfill the unmet requirements of consumer for innovative, low-dose joint health solutions across China.
Global Chondroitin Sulfate Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Source, Application, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Personal Care & Cosmetics
Rest of the World